For adults with moderate to severe ulcerative colitis (UC) in whom TNF blockers did not work well


Choosing a treatment for ulcerative colitis


RINVOQ helped patients achieve remission at 8 weeks and 1 year

What matters most to you in a UC treatment?

As you and your gastroenterologist discuss treatment options, consider what you’re looking to achieve. Pick a topic to learn more:

Symptom relief

Go for relief that’s fast—and lasts.

Steroid-free remission

Go beyond symptom relief and start moving toward lasting remission—without the need for steroids.

Visible colon lining repair*

Help repair UC damage from uncontrolled inflammation—even when symptoms are at bay.

*Areas that were visually assessed may not represent repair of the entire colon lining.

Safety Considerations

RINVOQ may cause serious side effects, including:

  • Serious infections. RINVOQ can lower ability to fight infections. Serious infections, some fatal, occurred, including tuberculosis (TB) and infections caused by bacteria, fungi, or viruses.
  • Increased risk of death in people age 50+ with at least 1 heart disease risk factor.
  • Cancer and immune system problems. Increased risk of some cancers, including lymphoma and skin. Current or past smokers have higher risk for lymphoma and lung cancer.
  • Increased risk of major cardiovascular events such as heart attack, stroke, or death in people 50+ with at least 1 heart disease risk factor, especially in current or past smokers.
  • Blood clots, some fatal, in veins of the legs or lungs and arteries. This occurred more often in people 50+ with at least 1 heart disease risk factor.
  • Serious allergic reactions. Do not take if allergic to RINVOQ or its ingredients.
  • Tears in the stomach or intestines; changes in certain laboratory test results.

Learn more about these and the full Important Safety Information below.

Find answers to frequently asked questions about RINVOQ >